Recent Finacing
Recent Raise
Nautilus Neurosciences develops neurology therapeutics, commercializing CAMBIA (water-soluble diclofenac potassium powder) for acute migraine and advancing PRO-571 as an acute pain treatment candidate.
Focus Areas
Recent Investors
Funding round
Investor